Find An Allergist / Immunologist | Pollen Counts | Journal of Allergy and Clinical Immunology | Annual Meeting   Site Map   Contact   Home    Search
Members Member Resources AAAAI News AAAAI eNews AAAAI Job Placement Center Promoting your Practice Order Public Education Materials Disease Management/ Ask the Expert Allergy, Asthma & Immunology Education and Research Trust (ART) Journal of Allergy and Clinical Immunology 2007 Accomplishments Annual Meeting Executive Staff Contacts Online Membership Directory AAAAI Organizational Structure » Members Contact AAAAI: Professional Home for the Practicing Allergist Grants and Awards Hot Topics Joint Council of Allergy, Asthma and Immunology (JCAAI) ST*AR Program AAAAI Assembly overview Allied Health Federation of the RSLAAI Societies International Military Allergy New Allergist/Immunologist Assembly Program Directors Organizational Chart Board of Directors Interest Sections Committees Fellows-in-Training Allied Health Professional Assembly Federation of RSLAAIS International Assembly Military Allergy Assembly New Allergist/Immunologist Assembly Program Directors Associates		Resources: IVIG Toolkit The AAAAI Primary Immunodeficiency Diseases (PID) Committee has created an IVIG toolkit to educate payers and regulators who are responsible for coverage determinations, and aid physicians in the safe, effective and appropriate use of IVIG for patients with primary immunodeficiency diseases. The IVIG toolkit includes: Eight guiding principles for safe, effective and appropriate use of IVIG (PDF) Guidelines for the site of care of the administration of IVIG therapy for patients with PID (PDF) AAAAI Work Group Report: The Appropriate Use of Intravenously Administered Immunoglobulin (IGIV) (PDF) "Use of intravenous immunoglobulin in human disease: A review of evidence by members of the primary immunodeficiency committee of the American Academy of Allergy Asthma & Immunology," published as a supplement to The Journal of Allergy and Clinical Immunology in April, 2006 (PDF) Letter to contract and medical directors to advocate for the coverage of IVIG (PDF) The IVIG toolkit has been approved by the AAAAI Board of Directors, and endorsed by the Clinical Immunology Society (CIS) and the Immune Deficiency Foundation (IDF). For more information or to obtain a copy of the IVIG Toolkit, contact Carrye Jo Cony at the AAAAI executive office at (414) 272-6071 or e-mail cjcony@aaaai.org. <back>
		© 1996-2008 · All Rights Reserved · American Academy of Allergy Asthma & Immunology